A citation-based method for searching scientific literature

Angela Toss, Eleonora Molinaro, Margaret Sammarini, Maria C Del Savio, Laura Cortesi, Fabio Facchinetti, Giovanni Grandi. Minerva Med 2019
Times Cited: 11







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
Laura Cortesi, Elisabetta De Matteis, Angela Toss, Isabella Marchi, Veronica Medici, Giannina Contu, Anjeza Xholli, Giovanni Grandi, Angelo Cagnacci, Massimo Federico. Oncology 2017
16
63

Hereditary ovarian cancer: not only BRCA 1 and 2 genes.
Angela Toss, Chiara Tomasello, Elisabetta Razzaboni, Giannina Contu, Giovanni Grandi, Angelo Cagnacci, Russell J Schilder, Laura Cortesi. Biomed Res Int 2015
82
36

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
36

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
27

Current and future role of genetic screening in gynecologic malignancies.
Kari L Ring, Christine Garcia, Martha H Thomas, Susan C Modesitt. Am J Obstet Gynecol 2017
21
18


Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
Amy Finch, Patricia Shaw, Barry Rosen, Joan Murphy, Steven A Narod, Terence J Colgan. Gynecol Oncol 2006
259
18

Reactivity of a monoclonal antibody with human ovarian carcinoma.
R C Bast, M Feeney, H Lazarus, L M Nadler, R B Colvin, R C Knapp. J Clin Invest 1981
18

Seasonal onset of the menopause.
A Cagnacci, F S Pansini, A Bacchi-Modena, N Giulini, G Mollica, D De Aloysio, E Vadora, A Volpe. Maturitas 2005
9
22

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.
Kai Wang, Mingyao Li, Hakon Hakonarson. Nucleic Acids Res 2010
18

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
665
18

Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies.
Angela Toss, Marta Venturelli, Eleonora Molinaro, Stefania Pipitone, Elena Barbieri, Isabella Marchi, Elena Tenedini, Lucia Artuso, Sara Castellano, Marco Marino,[...]. Cancers (Basel) 2019
9
22

Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor.
William McLaren, Bethan Pritchard, Daniel Rios, Yuan Chen, Paul Flicek, Fiona Cunningham. Bioinformatics 2010
18

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
18


Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
Catherine A Shu, Malcolm C Pike, Anjali R Jotwani, Tara M Friebel, Robert A Soslow, Douglas A Levine, Katherine L Nathanson, Jason A Konner, Angela G Arnold, Faina Bogomolniy,[...]. JAMA Oncol 2016
115
18

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
371
18

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.
Bella Kaufman, Ronnie Shapira-Frommer, Rita K Schmutzler, M William Audeh, Michael Friedlander, Judith Balmaña, Gillian Mitchell, Georgeta Fried, Salomon M Stemmer, Ayala Hubert,[...]. J Clin Oncol 2015
18

Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis.
Katrina Armstrong, J Sanford Schwartz, Thomas Randall, Stephen C Rubin, Barbara Weber. J Clin Oncol 2004
110
18

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
128
18

Primary debulking surgery vs. interval debulking surgery for advanced ovarian cancer: review of the literature and meta-analysis.
Benito Chiofalo, Simone Bruni, Camilla Certelli, Isabella Sperduti, Ermelinda Baiocco, Enrico Vizza. Minerva Med 2019
6
16

Unraveling a difficult diagnosis: the tricks for early recognition of ovarian cancer.
Pierluigi Giampaolino, Luigi Della Corte, Virginia Foreste, Salvatore G Vitale, Benito Chiofalo, Stefano Cianci, Fulvio Zullo, Giuseppe Bifulco. Minerva Med 2019
19
9

Sexual function and quality of life of patients affected by ovarian cancer.
Stefano Cianci, Mattia Tarascio, Andrea Rosati, Salvatore Caruso, Stefano Uccella, Francesco Cosentino, Giuseppe Scaletta, Salvatore Gueli Alletti, Giovanni Scambia. Minerva Med 2019
11
9

From palliation to cure: PIPAC for peritoneal malignancies.
Andrea Di Giorgio, Carlo Abatini, Miriam Attalla El Halabieh, Emanuele Vita, Giuseppe Vizzielli, Valerio Gallotta, Fabio Pacelli, Stefano Rotolo. Minerva Med 2019
6
16

Role of ultrasound in advanced peritoneal malignancies.
Ilaria De Blasis, Maria C Moruzzi, Francesca Moro, Floriana Mascilini, Stefano Cianci, Salvatore Gueli Alletti, Luigi C Turco, Giorgia Garganese, Giovanni Scambia, Antonia C Testa. Minerva Med 2019
8
12

New medical approaches in advanced ovarian cancer.
Giacomo Corrado, Eleonora Palluzzi, Carolina Bottoni, Antonella Pietragalla, Vanda Salutari, Viola Ghizzoni, Mariagrazia Distefano, Giovanni Scambia, Gabriella Ferrandina. Minerva Med 2019
4
25

The role of sentinel node in early ovarian cancer: a systematic review.
Stefano Uccella, Pier Carlo Zorzato, Gabriele Lanzo, Anna Fagotti, Stefano Cianci, Davide Gallina, Salvatore Gueli Alletti, Giorgia Monterossi, Massimo Franchi, Fabio Ghezzi,[...]. Minerva Med 2019
9
11

Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature.
Salvatore Gueli Alletti, Vito A Capozzi, Andrea Rosati, Ilaria De Blasis, Stefano Cianci, Giuseppe Vizzielli, Stefano Uccella, Valerio Gallotta, Francesco Fanfani, Anna Fagotti,[...]. Minerva Med 2019
14
9

Mutations in BRIP1 confer high risk of ovarian cancer.
Thorunn Rafnar, Daniel F Gudbjartsson, Patrick Sulem, Aslaug Jonasdottir, Asgeir Sigurdsson, Adalbjorg Jonasdottir, Soren Besenbacher, Pär Lundin, Simon N Stacey, Julius Gudmundsson,[...]. Nat Genet 2011
239
9

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
Russell Vang, Ie-Ming Shih, Robert J Kurman. Histopathology 2013
168
9

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Sheila Seal, Deborah Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Katarina Spanova,[...]. Nat Genet 2006
493
9

The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.
Honglin Song, Mine S Cicek, Ed Dicks, Patricia Harrington, Susan J Ramus, Julie M Cunningham, Brooke L Fridley, Jonathan P Tyrer, Jennifer Alsop, Mercedes Jimenez-Linan,[...]. Hum Mol Genet 2014
76
9

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
215
9

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Nana Weber-Lassalle, Jan Hauke, Juliane Ramser, Lisa Richters, Eva Groß, Britta Blümcke, Andrea Gehrig, Anne-Karin Kahlert, Clemens R Müller, Karl Hackmann,[...]. Breast Cancer Res 2018
37
9


A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Mona A Karlsen, Estrid V S Høgdall, Ib J Christensen, Christer Borgfeldt, Grigorios Kalapotharakos, Lenka Zdrazilova-Dubska, Josef Chovanec, Christianne A R Lok, Anna Stiekema, Irene Mutz-Dehbalaie,[...]. Gynecol Oncol 2015
49
9

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
Vladimir Nossov, Malaika Amneus, Feng Su, Jennifer Lang, Jo Marie Tran Janco, Srinivasa T Reddy, Robin Farias-Eisner. Am J Obstet Gynecol 2008
189
9

Peripheral biomarkers of endometriosis: a systematic review.
K E May, S A Conduit-Hulbert, J Villar, S Kirtley, S H Kennedy, C M Becker. Hum Reprod Update 2010
218
9

Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
Borut Kobal, Marco Noventa, Branko Cvjeticanin, Matija Barbic, Leon Meglic, Marusa Herzog, Giulia Bordi, Amerigo Vitagliano, Carlo Saccardi, Erik Skof. Radiol Oncol 2018
19
9

Etiology and pathogenesis of epithelial ovarian cancer.
Samuel C Mok, Joseph Kwong, William R Welch, Goli Samimi, Laurent Ozbun, Tomas Bonome, Michael J Birrer, Ross S Berkowitz, Kwong-Kwok Wong. Dis Markers 2007
29
9

Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer.
F Nagele, E Petru, M Medl, C Kainz, A H Graf, P Sevelda. Obstet Gynecol 1995
75
9


Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
Ronny Drapkin, Hans Henning von Horsten, Yafang Lin, Samuel C Mok, Christopher P Crum, William R Welch, Jonathan L Hecht. Cancer Res 2005
352
9

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Richard G Moore, Amy K Brown, M Craig Miller, Steven Skates, W Jeffrey Allard, Thorsten Verch, Margaret Steinhoff, Geralyn Messerlian, Paul DiSilvestro, C O Granai,[...]. Gynecol Oncol 2008
422
9

Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer.
Anette Lykke Petri, Estrid Høgdall, Ib Jarle Christensen, Susanne Krüger Kjaer, Jan Blaakaer, Claus Kim Høgdall. APMIS 2006
13
9

Early detection and prognosis of ovarian cancer using serum YKL-40.
Jakob Dupont, Meena K Tanwar, Howard T Thaler, Martin Fleisher, Noah Kauff, Martee L Hensley, Paul Sabbatini, Sibyl Anderson, Carol Aghajanian, Eric C Holland,[...]. J Clin Oncol 2004
107
9

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
R C Bast, T L Klug, E St John, E Jenison, J M Niloff, H Lazarus, R S Berkowitz, T Leavitt, C T Griffiths, L Parker,[...]. N Engl J Med 1983
9


The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life.
Giovanni Grandi, Angela Toss, Laura Cortesi, Laura Botticelli, Annibale Volpe, Angelo Cagnacci. Biomed Res Int 2015
27
9

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.
Estrid V S Høgdall, Lise Christensen, Susanne K Kjaer, Jan Blaakaer, Anette Kjaerbye-Thygesen, Simon Gayther, Ian J Jacobs, Claus K Høgdall. Gynecol Oncol 2007
79
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.